查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2022-2029 年全球球囊后凸成形术器械市场
市场调查报告书
商品编码
1166512

2022-2029 年全球球囊后凸成形术器械市场

Global Balloon Kyphoplasty Devices Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

球囊后凸成形术设备的全球市场规模将在 2021 年达到 6.072 亿美元，在 2029 年达到 8.943 亿美元，预测期内（2022-2029 年）的复合年增长率为 5.81%。预计还会增长。

球囊后凸成形术是一种微创手术，旨在通过稳定骨折来修復椎骨压缩性骨折 (VCF)。 它治疗由骨质疏鬆症、癌症和良性病变引起的椎体病理性骨折。 与椎体成形术不同的球囊后凸成形术的主要优点是，在用球囊后凸成形术治疗骨折期间，椎体的高度得以恢復。

市场动态

球囊后凸成形术设备市场骨质疏鬆症的日益流行正在推动全球对球囊后凸成形术设备的需求。

预计骨质疏鬆症患病率上升和研发活动增加将推动市场增长。

骨质疏鬆症和骨质疏鬆性骨折是世界范围内的主要公共卫生问题。 当骨密度降低时，骨质疏鬆症就会发展，身体会更快地吸收骨组织，并且可用于替代骨组织的产品更少。 根据国际骨质疏鬆症基金会 2020，骨质疏鬆症是 VCF 的主要原因，每年导致超过 890 万例骨折，或每 3 秒发生一次骨质疏鬆性骨折。 骨质疏鬆性椎体压缩性骨折 (OVCF) 是一个主要的健康问题，会降低生活质量并增加背痛。 骨质疏鬆症约占椎骨压缩性骨折的 85%。 在美国，骨质疏鬆症会降低生活质量并增加与骨质疏鬆症相关的骨折。 约有 800 万女性患有骨质疏鬆症，约有 2200 万女性有患骨质疏鬆症的风险。 美国每年诊断出约 700,000 例椎骨骨折，其中 115,000 例入院治疗。 在美国，至少有二分之一的女性和四分之一的男性患有骨质疏鬆症相关的骨折。 骨质疏鬆症每年导致 200 万例骨折和 190 亿美元的相关费用。 到 2025 年，骨质疏鬆症预计每年将导致大约 300 万例骨折，并造成 253 亿美元的损失。

椎体压缩性骨折 (VCF) 也是由转移性骨病、转移性脊柱肿瘤、多发性骨髓瘤和外伤引起的。 VCF 患者接受椎体成形术或骨盆成形术以改善症状。 球囊后凸成形术 (KP) 是一种通过将充气球囊插入椎骨并使其膨胀来恢復椎骨高度的方法。 球囊装置的使用不同于椎板成形术。 通过将球囊逐渐充气并置入器械，可恢復椎体骨折前的形状和高度。 因此，预计在预测期内，对椎骨骨折诊断和治疗的需求不断增长将推动全球市场。

此外，设备技术进步的加快、各大公司加大研发投入以及各大公司之间的战略联盟也是推动球囊椎体后凸成形术设备市场全球增长的因素。. 例如，总部位于美国佛罗里达州的 PanMed 推出了 CurvePlus，这是一种曲线提升设备，可实现最简单、最快速、最完整的曲线提升程序。 该设备已获得 FDA 批准，是唯一可以通过弯曲针头用球囊和骨水泥填充受损椎骨的设备。

水泥洩漏风险、球囊成形术意识低下以及严格的监管指南预计会阻碍市场增长。

行业分析

根据各种行业因素，包括波特五力、监管分析、供应链分析、价格分析、流行病学、未满足的需求、报销方案和技术创新，预测全球球囊后凸成形术设备市场将增长。我们提供详细的分析。

内容

第1章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第4章市场动态

  • 市场影响因素
  • 司机
      • 骨质疏鬆症增加
      • 技术设备进展
  • 约束因素
      • 骨水泥渗漏和罕见中风的风险
  • 商机
  • 影响分析

第5章行业分析

  • 波特的五力分析
  • 流行病学
  • 监管分析
  • 保险报销场景
  • 创新
  • 供应链分析
  • 定价分析
  • 未满足的需求

第 6 章组件

  • 骨骼访问工具
  • 用于骨折復位的球囊和充气装置
  • 骨水泥和水泥供应
  • 其他配件

第 7 章最终用户

  • 医院和诊所
  • 门诊手术中心 (ASC)
  • 其他

第8章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
      • 各地区的主要动态
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲
  • 南美洲
      • 各地区的主要动态
      • 巴西
      • 阿根廷
      • 其他南美洲
  • 亚太地区
      • 各地区的主要动态
      • 中国
      • 印度
      • 日本
      • 澳大利亚
      • 其他亚太地区
  • 中东和非洲
      • 各地区的主要动态

第9章竞争格局

  • 竞争场景
  • 市场定位/市场份额分析
  • 併购分析

第10章公司简介

  • 美敦力
    • 公司概况
    • 产品组合和说明
    • 主要亮点
    • 财务摘要
  • Stryker
  • Johnson & Johnson（DePuy Synthes）
  • Cook Medical
  • Zimmer Biomet
  • CareFusion（BD）
  • Tecres
  • Bone Support
  • AOI Medical
  • Benvenue Medical

第11章 球囊后凸成形术设备的全球市场-DataM

简介目录
Product Code: DMMD2041

Market Overview

The global balloon kyphoplasty devices market size was valued US$ 607.2 million in 2021 and is estimated to reach US$ 894.3 million by 2029, growing at a CAGR of 5.81% during the forecast period (2022-2029).

Balloon kyphoplasty is a minimally invasive procedure intended to repair vertebral compression fractures (VCFs) by stabilizing the fractures. It treats pathological fractures of the vertebral body due to osteoporosis, cancer, or benign lesions. The main advantage of balloon kyphoplasty that differentiates it from vertebroplasty is that the vertebral height is restored while treating the fracture through balloon Kyphoplasty.

Market Dynamics

The balloon kyphoplasty devices market is driven by the rising prevalence of osteoporosis, which increases the demand for balloon kyphoplasty devices globally.

Increasing prevalence of osteoporosis and rising R&D activities are expected to drive market growth.

Osteoporosis the and osteoporotic fractures are a major public health problem globally. Osteoporosis develops, density decreases, and the body reabsorbs more bone tissue and produces less to replace it. According to the International Osteoporosis Foundation 2020, osteoporosis is the main cause of VCF, which causes more than 8.9 million fractures each year, i.e., one osteoporotic fracture every three seconds. Osteoporotic vertebral compression fractures (OVCF) comprise a major health problem that decreases life quality and increases back pain. Osteoporosis accounts for about 85% of overall VCF cases. In the US, it decreases life quality and increases seoporosis-related fractures. About eight million women have osteoporosis, and about 22 million are at risk of developing the disease. Around 700,000 vertebral body fractures are diagnosed annually in the US, with 115,000 being admitted to hospitals for treatment. At least one in two women and one in four men in the US suffer from osteoporosis-related fractures. Osteoporosis is responsible for two million broken bones and $19 billion in related costs every year. By 2025, it is predicted that osteoporosis will be responsible for approx.-three million fractures and US$25.3 billion in costs annually.

Vertebral compression fractures (VCF) are also caused by metastatic bone disease, metastatic spinal tumors, multiple myeloma, and traumatic injuries. Individuals with VCF undergo either vertebroplasty or kyphoplasty to rectify the condition. Balloon kyphoplasty (KP) is a procedure wherein a deflated balloon is inserted into the vertebral body through the pedicle and then inflated to restore the height of a collapsed vertebral body. The usage of balloon devices makes kyphoplasty different from vertebroplasty. The gradual inflation of balloon and devices insertion helps restore the pre-facture shape and height of the vertebral bodies. Hence, the rising demand for the diagnosis and treatment of vertebral fractures is projected to drive the global market during the forecast period.

Besides, growing technological advancements in the devices, increasing R&D investment by major players, and strategic alliances among major companies are some of the other factors boosting the growth of the balloon kyphoplasty devices market globally. For instance, PanMed U.S., based in Florida, launched the CurvePlus, a curved kyphoplasty device that allows the simplest, quickest, most complete curved kyphoplasty procedure. It is FDA approved and is only one that permits both balloon and cement to pass through curved needle to fill injured vertebra.

Risk of cement leakage and unawareness are expected to hamper the market growth.

The risk of cement leakage and rare occurrence of stroke, low awareness towards balloon kyphoplasty and stringent regulatory guidelines are expected to hinder the growth of the market.

Industry Analysis

The global balloon kyphoplasty devices market provides in-depth analysis of the market based on various industry factors such as porter's five forces, regulatory analysis, supply chain analysis, pricing analysis, epidemiology, unmet needs, reimbursement scenario and technological innovations.

Segment Analysis

Balloon and inflation devices segment is expected to hold the largest market share in global balloon kyphoplasty devices market

On the basis of component type, the global balloon kyphoplasty devices market is segmented into balloons & inflation devices, bone access tools, bone cement & delivery systems, and accessories. Among these, balloon and inflation devices for recovery of fractures accounted for the largest market share due to the rising demand for these devices in complicated fracture cases. In addition, manufacturers are innovating new technologically advanced products, which are contributing to the major share of this segment during the forecast period.

Medtronic has launched the new Kyphon Xpander II IBT System, which includes the Kyphon Xpander II Inflatable Bone Tamp (IBT) and the Kyphon Inflation Syringe manufactured by Medtronic is used for the treatment of vertebral compression fractures. It is combined with the Kyphon Inflation Syringe, which provides ease of use to customers for use during a balloon kyphoplasty procedure.

Geographical Analysis

North America region holds the largest market share in the global balloon kyphoplasty devices market

North America holds the dominant market share for balloon kyphoplasty devices. Due to the rising number of vertebral compression fracture cases in the U.S., growing geriatric population, technological advancement in balloon kyphoplasty devices, it is expected to maintain the growth over the forecast period well-established health care infrastructure, and high diagnosis & treatment rates of fractures. Osteoporosis, a condition characterized by low bone mass and deterioration in the microarchitecture of bone tissue, causes more than 700,000 spinal fractures each year in the U.S. (2019). The prevalence of osteoporosis is projected to rise in the United States from approximately 13 million people to more than 16 million people by 2022. Though osteoporosis is mostly associated with women, it is also diagnosed in men, who account for an estimated 1 in 5 Americans who have osteoporosis. According to the Centers for Disease Control and Prevention (2021), in the US, 5.1% of men (65 years of age & over) are diagnosed with osteoporosis of the femur neck or lumbar spine, and 24.5% of women 65 years of age & over are diagnosed with osteoporosis of the femur neck or lumbar spine. With the rising number of osteoporosis cases in this region, the demand for diagnosis and treatment is increasing, which results in the e growth of the balloon kyphoplasty market in this region.

Competitive Landscape

The balloon kyphoplasty devices market is highly competitive with presence of large number of players including Medtronic, Stryker, Johnson & Johnson (DePuy Synthes), Cook Medical, Zimmer Biomet, CareFusion, Tecres, Bone Support, AOI Medical, and Benvenue Medical.

The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations which are contributing to the growth of the balloon kyphoplasty devices market globally. For instance,

  • In Sep 2022, Aurora Spine Corporation announced approval of its novel lumbar spinal stenosis by FDA. Indicating its usage with Aurora ZIP Platform.
  • In Jul 2022, Zavation Medical Products announced approval of its novel expandable lumbar interbody fusion device, eZspand Lateral by FDA.
  • In Jun 2022, Onkos surgical announced agreement with Stryker for acquiring Juvenile Tumour System, a prosthetic system for bone cancer pediatric patients.
  • In Jun 2022, Stryker announced approval of Q guidance system by FDA. It is advance planning guidance system that is intra-operative and is utilized during spinal surgery.
  • In May 2021, Safe Orthopaedics, a company offering innovative ranges of sterile implants combined with their single-use instruments for back surgery, announced CE mark approval for its novel treatment for osteoporotic patients known as Hickory.

Key Companies to Watch

Medtronic:

Overview: Medtronic plc is an American company that operates in U.S. and manufactures and markets medical device headquarters in Minneapolis, US. It is operational in around 140 countries and 90,000 people are employed there.

Product Portfolio:

Kyphon Balloon Kyphoplasty: With the help of orthopaedic balloons, it restores correct angular deformity and vertebral height from the vertebral compression fractures that are cause due to cancer, osteoporosis and benign lesion.

Key Developments: In May 2020, Medtronic announced U.S. launch of kyphon assisted directional cannula for using it with balloon kyphoplasty products for the treatment of vertebral compression fractures due to cancer and osteoporosis.

The global balloon kyphoplasty devices market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
  • 4.2. Drivers
      • 4.2.1.1. Rising prevalence of osteoporosis
      • 4.2.1.2. Advancement in technological devices
  • 4.3. Restraints
      • 4.3.1.1. Risk of cement leakage and rare occurrence of stroke
  • 4.4. Opportunity
  • 4.5. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Epidemiology
  • 5.3. Regulatory Analysis
  • 5.4. Reimbursement Scenario
  • 5.5. Technological Innovations
  • 5.6. Supply Chain Analysis
  • 5.7. Pricing Analysis
  • 5.8. Unmet Needs

6. By Component

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component Segment
    • 6.1.2. Market Attractiveness Index, By Component Segment
  • 6.2. Bone access tools
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Balloons and inflation devices for fracture reduction
  • 6.4. Bone cement and cement delivery
  • 6.5. Other accessories

7. By End-User

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User Segment
    • 7.1.2. Market Attractiveness Index, By End-User Segment
  • 7.2. Hospitals & Clinics
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Ambulatory Surgical Centers (ASCs)
  • 7.4. Others

8. By Region

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
    • 8.1.2. Market Attractiveness Index, By Region
  • 8.2. North America
      • 8.2.1.1. Introduction
      • 8.2.1.2. Key Region-Specific Dynamics
      • 8.2.1.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
      • 8.2.1.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
      • 8.2.1.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.2.1.5.1. U.S.
      • 8.2.1.5.2. Canada
      • 8.2.1.5.3. Mexico
  • 8.3. Europe
      • 8.3.1.1. Introduction
      • 8.3.1.2. Key Region-Specific Dynamics
      • 8.3.1.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
      • 8.3.1.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
      • 8.3.1.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.3.1.5.1. Germany
      • 8.3.1.5.2. U.K.
      • 8.3.1.5.3. France
      • 8.3.1.5.4. Italy
      • 8.3.1.5.5. Spain
      • 8.3.1.5.6. Rest of Europe
  • 8.4. South America
      • 8.4.1.1. Introduction
      • 8.4.1.2. Key Region-Specific Dynamics
      • 8.4.1.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
      • 8.4.1.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
      • 8.4.1.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.4.1.5.1. Brazil
      • 8.4.1.5.2. Argentina
      • 8.4.1.5.3. Rest of South America
  • 8.5. Asia Pacific
      • 8.5.1.1. Introduction
      • 8.5.1.2. Key Region-Specific Dynamics
      • 8.5.1.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
      • 8.5.1.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
      • 8.5.1.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.5.1.5.1. China
      • 8.5.1.5.2. India
      • 8.5.1.5.3. Japan
      • 8.5.1.5.4. Australia
      • 8.5.1.5.5. Rest of Asia Pacific
  • 8.6. The Middle East and Africa
      • 8.6.1.1. Introduction
      • 8.6.1.2. Key Region-Specific Dynamics
      • 8.6.1.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
      • 8.6.1.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

9. Competitive Landscape

  • 9.1. Competitive Scenario
  • 9.2. Market Positioning/Share Analysis
  • 9.3. Mergers and Acquisitions Analysis

10. Company Profiles

  • 10.1. Medtronic
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio and Description
    • 10.1.3. Key Highlights
    • 10.1.4. Financial Overview
  • 10.2. Stryker
  • 10.3. Johnson & Johnson (DePuy Synthes)
  • 10.4. Cook Medical
  • 10.5. Zimmer Biomet
  • 10.6. CareFusion (BD)
  • 10.7. Tecres
  • 10.8. Bone Support
  • 10.9. AOI Medical
  • 10.10. Benvenue Medical

LIST NOT EXHAUSTIVE

11. Global Balloon Kyphoplasty Devices Market - DataM

  • 11.1. Appendix
  • 11.2. About Us and Method of Fixation
  • 11.3. Contact Us